Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly ...

Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.43 ...

Integra LifeSciences maintained its revenue outlook for the year but reduced its adjusted earnings per-share range to $2.19 to $2.29 to reflect an estimated hit of 22 cents a share from new tariffs.

Integra LifeSciences’ quality control issues persist, but new leadership offers hope. Find out why IART stock may offer opportunities despite risks.

Integra LifeSciences Holdings Corporation’s stock is up 7% in 2025, down 6.8% in the previous five trading days and down 43.25% in the past year. Currently, Integra LifeSciences Holdings Corporation ...

Forward-looking statements in this news release should be evaluated together with the many risks and uncertainties that affect Integra’s business and market which include but are not limited to: the ...

Analyst Price Forecast Suggests 63.86% Upside As of September 25, 2024, the average one-year price target for Integra LifeSciences Holdings is $28.56/share. The forecasts range from a low of $20. ...

The Tineco S5 Combo is a versatile cordless vacuum cleaner with automatic suction adjustment. It offers a long battery life and is perfect for homes with pets.

Why did Integra Lifesciences lower its guidance? In May, Integra's full-year outlook was for revenue between $1.672 billion and $1.687 billion, with adjusted EPS of $3.01 to $3.11.